Bioventus
Rating
Key Statistics
Market Data
Valuation (TTM)
Valuation (NTM)
Cash Flow
Margins
Growth (CAGR)
Returns
Financial Health
Dividends
Profile
Bioventus Inc., a medical device company, focuses on relieving pain and addressing musculoskeletal therapies in the United States and internationally. The company’s product portfolio includes pain tre...
Latest News
21 days ago · globenewswire.com
Bioventus to Report Third Quarter of Fiscal Year 2026 Financial Results on November 2, 2026DURHAM, N.C., Oct. 27, 2026 (GLOBE NEWSWIRE) -- Bioventus Inc. (Nasdaq: BVS) (“Bioventus” or the “Company”), a global leader in innovations for active healing, today announced that it will report financial results for the third quarter of fiscal year 2026 after the market closes on Monday, November 2, 2026. The Company's management will host a conference call at 4:30 p.m. Eastern Time that same day to discuss the results and provide a business update.
Earnings
Analyst Summary
Add to Watchlist
Select watchlists to add or remove BVS